AzTrials
AzTrials

Adhesive SystemNCT06899386

Evaluation Of the BEAUTIBOND XTREME Adhesive in Class I and II Restorations: One-Year Results.

A study testing Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS, Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS: and Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS in people with Adhesive System, run by University of Sao Paulo at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This randomized clinical trial aimed to evaluate the performance of the Beautibond Xtreme adhesive system under different bonding techniques. Patients over 18 years old with restorative needs were selected, and 152 teeth were randomized using the "Research Randomizer Program" for allocation into control groups (CI … Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Adhesive System
What is being tested?
Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS, Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS: and Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS
Could I receive a placebo?
No, everyone receives an active treatment
How many people
22 participants
Where
1 siteBrazil
Study dates
1 Apr 2023to 1 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18 years or older
  • Occlusal stability supported by molars, Presence of at least one premolar or one molar with Class I/II cavities suitable for direct restoration or restoration replacement
  • Ability to attend evaluation and regular maintenance appointments
  • No clinical symptoms or radiographic signs suggesting pulp involvement
  • No periodontal pockets or compromised biological space invasion
  • Ability to perform absolute isolation of the operative field and subsequent restoration of the cavity with composite resin
Show all 9Show fewer
  • Active carious lesion
  • Occlusal/occlusoproximal surface of molars and premolars, with a radiographic image showing shallow, medium, or deep dentin involvement, which is preventing the patient from effectively controlling bacterial biofilm, or showing some type of sensitivity
  • Cavity preparation margins (cavosurface) in enamel or dentin.

Who cannot join

  • Poor oral hygiene control
  • Patients undergoing orthodontic treatment
  • Pregnant or lactating women
  • Oral complications such as: bruxism, other parafunctional habits reinforcing the diagnosis of TMD (temporomandibular disorders), periodontal problems
  • Pregnant or breastfeeding women
  • Presence of uncontrolled systemic diseases
  • Patients at high risk for caries.

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Ribeirão Preto School of Dentistry of the University of São Paulo (FORP-USP)

    Ribeirão Preto, São Paulo, 14040-904

Other trials in Brazil

About this study

Official title: A Randomized Prospective Clinical Study Evaluating the Effectiveness of the BEAUTIBOND XTREME Adhesive System Using Different Bonding Techniques in Class I and II Restorations: One-Year Results.

This randomized clinical trial aimed to evaluate the performance of the Beautibond Xtreme adhesive system under different bonding techniques. Patients over 18 years old with restorative needs were selected, and 152 teeth were randomized using the "Research Randomizer Program" for allocation into control groups (CI - Class I restoration with total-etch conditioning; CII - Class II restoration with total-etch conditioning) and test groups (TI - Class I restoration in self-etch mode; TII - Class II restoration in self-etch mode; TIII - Class I restoration with selective enamel etching; TIV - Class II restoration with selective enamel etching). The restorations were evaluated (USPHS criteria) regarding anatomy, integrity, marginal staining, color, roughness, secondary caries lesions, postoperative sensitivity, and retention. Two calibrated examiners (Kappa test 0.84), blinded to the treatments, conducted evaluations for up to one year.

Conditions
Adhesive System
Being tested
Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS, Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS:, Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS
Keywords
adhesive system, randomized clinical trial

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LSOther

    Also called total-etch technique

    the enamel was etched for 30 seconds and the dentin for 15 seconds using 35% phosphoric acid gel (Ultradent). The acid was then rinsed off, and excess moisture was removed with an air spray. To protect the dentin during air blasting, an absorbent paper was held over it using clinical tweezers, ensuring a whitish appearance for the enamel and slightly moist dentin. Excess water on the cotton roll was dried as well. The BeautiBond Xtreme adhesive system was applied without any waiting time, followed by a gentle air spray for 3 seconds and then a strong air blast to ensure solvent evaporation. Finally, the adhesive was light-cured for 5 seconds using a LED photopolymerizer (Gran Valo LED Curing Light, Ultradent).

  • Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS:Other

    Also called self-etch technique

    no acid etching was performed on either the enamel or dentin. The BeautiBond Xtreme adhesive system was applied immediately, without any waiting time, followed by a gentle air spray for 3 seconds and then a strong air blast to ensure solvent evaporation. The adhesive was then light-cured for 5 seconds using a LED photopolymerizer (Gran Valo LED Curing Light, Ultradent).

  • Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LSOther

    Also called selective acid-etch technique

    the enamel was etched for 15 seconds using 35% phosphoric acid gel (Ultradent). The acid was then rinsed off, and excess moisture was removed with an air spray, leaving the enamel with a whitish appearance. Excess water on the cotton roll was also dried. Next, the BeautiBond Xtreme adhesive system was applied immediately, without any waiting time, followed by a gentle air spray for 3 seconds and then a strong air blast to ensure solvent evaporation. The adhesive was then light-cured for 5 seconds using a LED photopolymerizer (Gran Valo LED Curing Light, Ultradent).

Study groups in NCT06899386
Study groupRoleWhat they receive
CI: Class I cavities restored with the total acid-etching technique.ExperimentalClass I cavities restored with the total acid-etching technique.
Receives: Other: Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS
CII: Class II cavities restored with the total acid-etching technique.ExperimentalClass II cavities restored with the total acid-etching technique.
Receives: Other: Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS
TI: Class I cavities restored with the self-etching technique.ExperimentalClass I cavities restored with the self-etching technique.
Receives: Other: Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS:
TII: Class II cavities restored with the self-etching technique.ExperimentalClass II cavities restored with the self-etching technique.
Receives: Other: Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS:
TIII: Class I cavities restored with the select-etching technique.ExperimentalClass I cavities restored with the select-etching technique
Receives: Other: Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS
TIV: Class II cavities restorCed with the select-etching technique.ExperimentalClass II cavities restorCed with the select-etching technique.
Receives: Other: Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anatomic Form

    The anatomic form of the restoration was evaluated according to the modified United States Public Health Service (USPHS) criteria at baseline, six months, and one year. Restorations were classified as Alpha (continuity of the restoration with the existing anatomic form), Bravo (continuity of the restoration with partial degradation but clinically acceptable), or Charlie (continuity of the restoration compromised, requiring replacement).

    Measured: baseline, six months, and one year.

  2. Marginal Adaptation

    Marginal adaptation was visually analyzed using an explorer to detect crevices or marginal failures. Classifications included Alpha (no visible evidence of a crevice along the margin), Bravo (visible evidence of a crevice along the margin where the explorer can penetrate or catch), and Charlie (the explorer penetrates the crevice, exposing dentin or base).

    Measured: baseline, six months, and one year.

  3. Marginal Discoloration

    Marginal discoloration was assessed by recording any color changes at the interface between the restoration and tooth structure. Restorations were classified as Alpha (no visible discoloration), Bravo (discoloration present but not penetrating along the margin in a pulpal direction), or Charlie (deep discoloration penetrating along the margin toward the pulp).

    Measured: baseline, six months, and one year.

  4. Secondary Caries

    The presence of secondary caries was clinically and radiographically evaluated throughout the study. Restorations were classified as Alpha (no evidence of secondary caries) or Charlie (evidence of secondary caries around the restoration, requiring replacement).

    Measured: baseline, six months, and one year.

  5. Color Match

    Color match was evaluated by comparing the restoration to the adjacent tooth structure in terms of color and translucency. Classifications included Alpha (color and translucency compatible with the tooth structure), Bravo (color and translucency mismatch within the acceptable range), and Charlie (color and translucency mismatch outside the acceptable range).

    Measured: baseline, six months, and one year.

  6. Postoperative Sensitivity

    Postoperative sensitivity was assessed through patient reports at different study periods. Classifications included Alpha (no postoperative sensitivity after the restorative procedure and throughout the study), Bravo (slight sensitivity at any stage of the study), and Charlie (severe sensitivity at any stage of the study).

    Measured: baseline, six months, and one year.

  7. Surface Texture

    The surface texture of the restoration was visually and tactilely evaluated using an explorer. Restorations were classified as Alpha (no surface defects), Bravo (minimal surface defects), or Charlie (severe surface defects on the restoration).

    Measured: baseline, six months, and one year.

  8. Retention

    Retention was evaluated by verifying the presence of the restoration over time. Classifications included Alpha (no loss of restorative material) and Charlie (fracture and/or total loss of the restorative material).

    Measured: baseline, six months, and one year.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Mar 2025
  2. Study start1 Apr 2023
  3. Primary completion1 Oct 2023
  4. Study completion1 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
22 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06899386
Sponsor's protocol ID
61246422.4.0000.5498
Status last verified
Mar 2025
First submitted
14 Mar 2025
Last updated
28 Mar 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Group CI and CII - BeautiBond Xtreme (total-etch technique) + Beautifil LS, Group TI and TII - BeautiBond Xtreme (self-etch technique) + Beautifil LS: and Group TIII and TIV - BeautiBond Xtreme (selective acid-etch technique) + Beautifil LS in people with Adhesive System, run by University of Sao Paulo at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anatomic Form (time frame: baseline, six months, and one year.). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in